Discover, September 21, 2010.
An FDA advisory panel has decided what it thinks about genetically modified salmon, and its decision is to not make a decision. The committee says it doesn’t have enough data to fully support approving the biotech salmon, which would make it the first such animal in the country.
“We are missing data,” said panel member James McKean, a professor at Iowa State University. He said that “leaves a cloud” over the FDA staff’s analysis.
But some other panel members agreed with the FDA’s position that the fish was fine. Read More >